Focusing on EZH2 and CBX2, we investigated whether elevated expression of these two PcG members also occurred in small cell lung cancer (SCLC), since it represents a neuroendocrine malignancy that closely resembles NEPC histologically and molecularly [34,35]. This evidence concerns the gene CBX2 and small cell lung carcinoma.